Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Kotrova

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Blood|October 14, 2022
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocolMichael Svaton, Aneta Skotnicova, Leona Reznickova, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cellsMartin Thelen, Diandra Keller, Jonas Lehmann, et al.
Molecular Immunology|February 7, 2015
Polyclonal, newly derived T cells with low expression of inhibitory molecule PD-1 in tonsils define the phenotype of lymphocytes in children with Periodic Fever, Aphtous Stomatitis, Pharyngitis and Adenitis (PFAPA) syndromePetra Dytrych, Petra Krol, Dytrych Petra, et al.
Cancers|January 20, 2021
Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune DiseasesStefan Porubsky, Zoran V Popovic, Sunil Badve, et al.
Leukemia|May 14, 2024
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelinesVincent H J van der Velden, Isabel Dombrink, Julia Alten, et al.
Blood|March 25, 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturationMichaela Kotrova, Constantin Proske, Nikos Darzentas, et al.
Blood|October 28, 2020
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1Sarah Reinke, Paul J Bröckelmann, Ingram Iaccarino, et al.
Hemasphere|February 26, 2026
Intra-subtype heterogeneity shapes treatment response in <i>KMT2A</i>-rearranged ALL across all age groupsAlina M Hartmann, Lorenz Bastian, Malwine J Barz, et al.
Blood|March 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple MyelomaJohanna M Horns, Thomas Beder, Axel Künstner, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Blood|October 14, 2022
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocolMichael Svaton, Aneta Skotnicova, Leona Reznickova, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cellsMartin Thelen, Diandra Keller, Jonas Lehmann, et al.
Molecular Immunology|February 7, 2015
Polyclonal, newly derived T cells with low expression of inhibitory molecule PD-1 in tonsils define the phenotype of lymphocytes in children with Periodic Fever, Aphtous Stomatitis, Pharyngitis and Adenitis (PFAPA) syndromePetra Dytrych, Petra Krol, Dytrych Petra, et al.
Cancers|January 20, 2021
Thymic Hyperplasia with Lymphoepithelial Sialadenitis (LESA)-Like Features: Strong Association with Lymphomas and Non-Myasthenic Autoimmune DiseasesStefan Porubsky, Zoran V Popovic, Sunil Badve, et al.
Leukemia|May 14, 2024
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelinesVincent H J van der Velden, Isabel Dombrink, Julia Alten, et al.
Blood|March 25, 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturationMichaela Kotrova, Constantin Proske, Nikos Darzentas, et al.
Blood|October 28, 2020
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1Sarah Reinke, Paul J Bröckelmann, Ingram Iaccarino, et al.
Hemasphere|February 26, 2026
Intra-subtype heterogeneity shapes treatment response in <i>KMT2A</i>-rearranged ALL across all age groupsAlina M Hartmann, Lorenz Bastian, Malwine J Barz, et al.
Blood|March 13, 2026
IDH2 Clonal Hematopoiesis and IKAROS Loss Cooperate in a B-ALL Subtype after Lenalidomide Therapy for Multiple MyelomaJohanna M Horns, Thomas Beder, Axel Künstner, et al.
Pageof 2